Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland
· Delayed Price · Currency is CHF 16.06
-0.20 (-1.23%)
Mar 3, 2025, 5:31 PM CET
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 45 employees as of December 31, 2023. The number of employees decreased by 1 or -2.18% compared to the previous year.
Employees
45
Change (1Y)
-1
Growth (1Y)
-2.18%
Revenue / Employee
2.52M CHF
Profits / Employee
1.40M CHF
Market Cap
202.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Alcon | 25,599 |
| Lonza Group AG | 18,686 |
| Galderma Group AG | 6,545 |
| Straumann Holding AG | 11,815 |
| Sandoz Group AG | 22,633 |
| Sonova Holding AG | 18,151 |
Santhera Pharmaceuticals Holding AG News
- 6 weeks ago - Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia - GlobeNewsWire
- 2 months ago - Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group - GlobeNewsWire
- 2 months ago - Santhera Announces Approval from China's NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy - Benzinga
- 6 months ago - Santhera Pharmaceuticals reports 1H results - Seeking Alpha
- 6 months ago - Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe - GlobeNewsWire